CO-LOCATED EVENTS
NextPrevious

Session

Challenge Your Peers Session 3

Thursday, June 12

04:45 PM - 05:45 PM

Live in Copenhagen

Less Details

  • How to successfully implement a SAM tool to replace decentralized systems?
  • How to align global and local SAM responsibilities while addressing organizational resistance?
  • How to identify and resolve data inconsistencies when consolidating SAM information?
  • How to measure the impact of SAM maturity on compliance, cost-efficiency, and cross-departmental collaboration?
Workshop

Speaker

Sisse Vestergaard Bech

Director, Head of IT Contract & License Management, Lundbeck A/S

Sisse is an experienced Senior Contract and License Manager with a strong background in IT agreements and Software Asset Management. Currently serving as Director and Head of IT Contract & License Management at Lundbeck, she leads a team of five, managing global software, contract, and licensing agreements within the pharmaceutical industry. Over her decade-long tenure at Lundbeck, Sisse has advanced through several leadership roles, excelling in strategic sourcing, compliance, negotiations, and vendor management. Her expertise includes developing SAM frameworks, ensuring audit readiness, and optimizing IT governance processes. Prior to Lundbeck, Sisse honed her skills in IT procurement and contract management at DONG Energy and Københavns Kommune, where she implemented centralized license management systems and advised on software compliance and legal challenges.

Company

Lundbeck A/S

Lundbeck is a global pharmaceutical company solely focused on neuroscience. We cover the full value chain, from molecule to patient, in this rapidly evolving area of treatment. For more than 70 years we have maintained our focus on neuroscience. Our legacy and commitment to breakthrough innovation provide the foundation for developing truly transformative treatments for neuro-rare and neuro-specialty conditions. We are 5,600 employees in more than 50 countries, and our products are available in more than 100 countries. We have research facilities in Denmark and the United States, and our production facilities are located in Denmark, France, and Italy. Our curiosity, accountability, and adaptability enable us to advance brain health and transform lives. Whether we work in labs, at desks, or in the field, we work closely with patients, healthcare professionals, and the neuroscience community to uncover causes, find new treatments, and fight stigma and discrimination. We want to go faster and further on addressing the significant unmet needs of people living with brain disorders.

NextPrevious